Angelos Stergiou is the founder of SELLAS Life Sciences Group. SELLAS Life Sciences Group has raised $25M in total funding. Latest round: Growth.
Angelos M. Stergiou is the President and CEO of SELLAS Life Sciences Group, a biopharmaceutical company listed on NASDAQ under the ticker SLS. He led the company's recent $25 million at-the-market raise in January 2026 to advance key data points and business development discussions.
Full founder directory · Investor directory · Company funding database · Fundraising library